eTable 5. Overall results for the comparison of intraoral appliances vs placebo on minimum oxygen saturation.
Data | Trials | Effect | 95% CI | p | 95% PrI | τ2 | I2 (%) | |
Meta-analysis | MD | 6 | 3.33 | [1.38; 5.28] | 0.007 | –1.62; 8.28 | 2.19 | 96.8 |
Factor | Data | Trials | Effect | 95% CI | p | τ2 | I2 (%) | |
Follow-up (months) | Coefficient | 5 | –0.37 | [–0.61; –0.14] | 0.015 | 0.26 | 45.6 | |
Constant | 7.2 | [4.69; 9.70] | 0.003 | |||||
% of maximum protrusion | Coefficient | NA | ||||||
Constant | ||||||||
Appliance type (1- or 2-piece) | Coefficient | 5 | 2.19 | [–13.13; 17.51] | 0.68 | 3.22 | 92 | |
Constant | 1.5 | [–38.15; 57.79] | 0.77 | |||||
Baseline BMI (kg/m2) | Coefficient | 6 | –0.22 | [–1.88; 1.43] | 0.725 | 2.7 | 92 | |
Constant | 9.82 | [–38.15; 57.79] | 0.6 | |||||
Baseline AHI (events/hour) |
NA | |||||||
Baseline age (years) | Coefficient | 6 | –0.27 | [–1.14; 0.60] | 0.129 | 1.35 | 94.9 | |
Constant | 16.42 | [–25.56; 58.39] | 0.2 | |||||
Ratio of male patients | Coefficient | 6 | 22.38 | [–10.19; 54.96] | 0.129 | 1.35 | 94.9 | |
Constant | –14.03 | [–39.43; 11.37] | 0.2 | |||||
Total sample | Coefficient | 6 | –0.05 | [–0.11; 0.00] | 0.06 | 0.9 | 51.5 | |
Constant | 6.48 | [2.91; 10.05] | 0.007 | |||||
Study design (crossover or parallel) |
Coefficient | 6 | 1.82 | [–3.34; 6.97] | 0.383 | 2.21 | 97.4 | |
Constant | 1.9 | [–2.67; 6.47] | 0.313 | |||||
Data type 1 | Coefficient | NA | ||||||
Constant | ||||||||
Data type 2 | Coefficient | 6 | –1.87 | [–14.97; 11.22] | 0.712 | 2.69 | 97.4 | |
Constant | 3.37 | [1.04; 5.70] | 0.016 | |||||
Data type 1 | Coefficient | NA | ||||||
Data type 2 | Coefficient | |||||||
Constant | ||||||||
Data | Trials | Effect | 95% CI | p | ||||
Reporting bias (Egger’s test) |
Coefficient | NA |
CI. confidence interval; PrI. predictive interval; MD. mean difference; NA. not applicable; BMI. body mass index; AHI. apnea hypopnea index; Data type 1. origin of data used in the analysis 1 (increment calculated from parallel or cross-over trials); Data type 2. origin of data used in the analysis 2 (increment calculated from final values of cross-over trials).